Trial intelligence / Profile preview

Bifidobacterium animalis subsp. lactis HN019 in Oral Lichen Planus

NCT03386643Phase 2Completed

Sponsor
Universidade de São Paulo
Start
Nov 2017
Primary completion
Apr 2018
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 2 trial of bifidobacterium animalis subsp lactis HN019 in oral lichen planus (OLP), sponsored by Universidade de São Paulo. Started Nov 2017; status: completed.

02

Drugs

bifidobacterium animalis subsp lactis HN019
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT03386643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03386643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call